Search results for "autoantibody"

showing 10 items of 249 documents

Autoantikörper gegen die Komplementkomponente C1q beim Systemischen Lupus Erythematodes

1990

Autoantibodies against C1q, a subcomponent of the first complement component C1, could be detected in 49.4% of sera from patients with systemic lupus erythematosus (SLE). They are directed against the collagen-like portion of the C1q molecule and recognize only bound, but not fluid-phase C1q. The appearance of these autoantibodies in the course of SLE correlates with the detection of IgG in the C1q-Solid-Phase-Bindingassay, with high titres of dsDNA-antibodies and with depressed total complement activity (CH50) and C1q-values. Our investigations show that autoantibodies against the collagen-like portion of bound C1q but not immune complexes are the main constituent of C1q-binding IgG in SLE.

business.industryAutoantibodychemical and pharmacologic phenomenaGeneral Medicineurologic and male genital diseasesComplement activityfluids and secretionsImmune systemimmune system diseasesDrug DiscoveryImmunologyMolecular MedicineMedicineskin and connective tissue diseasesbusinessGenetics (clinical)Anti-SSA/Ro autoantibodiesKlinische Wochenschrift
researchProduct

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

2006

Abstract Introduction: Acquired haemophilia (AcH) is associated with the development of polyclonal autoantibodies against FVIII, which affect directly the A2 or C2 domain of the FVIII molecule. Immunomodulatory therapy regimes to normalize FVIII levels and to eliminate the inhibitor are essential options in the treatment of patients (pts) with AcH. The aims of the present study were to investigate the response to Rituximab® and to localize the inhibitor epitopes on the FVIII domains. Patients and Methods: In 5 pts with AcH (2 females,3 males; age: 64–81 yrs) the inhibitor titers ranged from 9 to 156 BU and the FVIII activities from <1 % to 6 %. Rituximab® was administered once weekly…

business.industrymedicine.drug_classImmunologyAutoantibodyCell BiologyHematologyMonoclonal antibodyBiochemistryEpitopeTiterEpitope mappingMedian follow-upPrednisonehemic and lymphatic diseasesImmunologyMedicineRituximabbusinessmedicine.drugBlood
researchProduct

Hepatitic C virus infection and autoimmunity : clinical features, diagnostic tools and therapeutical aspects

1995

Summary Since the genom of the hepatitis C virus (HCV) was detected the pathogenesis of a distinct group of chronic liver disease and some non-hepatic disorders of sofar unknown origin could be newly established. A wide variety of clinical features including vasculitis, glomerulonephritis, porphyria and rheumatoid-like symptoms may become apparant separately or in combination. HCV can be precipitated in cryoglobulins and tissue-related HCV was found in liver and kidney specimen, for instance. HCV-related cryoglobulinemia or circulating immune complexes often occur with vasculitis. Hematological changes may be present such as thrombocytopenia. A considerable amount of patients show circulati…

business.industrymedicine.medical_treatmentHepatitis C virusAutoantibodyImmunosuppressionDiseasemedicine.disease_causemedicine.diseaseChronic liver diseaseCryoglobulinemiaVirologyAutoimmunityInfectious DiseasesImmunologymedicineVasculitisbusinessMédecine et Maladies Infectieuses
researchProduct

Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN201…

2021

IntroductionOxidative stress is one of many factors suspected to promote antinuclear autoantibody (ANA) formation. Reactive oxygen species can induce changes in the antigenic structure of macromolecules, causing the immune system to treat them as “neo-antigens” and start production of autoantibodies. This study was designed to evaluate the relationship between oxidative stress markers, lifestyle factors and the detection of ANA.Material and methodsWe examined measures of oxidative stress indices of free-radical damage to lipids and proteins, such as total oxidant status (TOS), concentration of protein thiol groups (PSH), and malondialdehyde (MDA), activity of superoxide dismutase (SOD) in i…

chemistry.chemical_classificationRMmedicine.medical_specialtyReactive oxygen speciesAntioxidantbiologybusiness.industrymedicine.medical_treatmentAutoantibodyGeneral MedicineOxidative phosphorylationMalondialdehydemedicine.disease_causeSuperoxide dismutasechemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicinebiology.proteinUric acidskin and connective tissue diseasesbusinessOxidative stressArchives of Medical Science
researchProduct

Epidemiology and pathogenesis of celiac disease and non-celiac gluten (wheat) sensitivity

2021

Abstract While in the past, celiac disease (CD) was considered the only clinical entity caused by the ingestion of gluten-containing grains, now there is evidence that a spectrum of gluten-related disorders, including also wheat allergy and non-celiac gluten (wheat) sensitivity (NCGS/NCWS), exists. The prevalence of gluten-related disorders is rising, and increasing numbers of individuals are empirically trying a gluten-free diet for a variety of signs and symptoms. CD is a gluten-induced immune-mediated enteropathy characterized by a specific genetic genotype [human leukocyte antigen (HLA)-DQ2 and HLA-DQ8 genes] and autoantibodies (antitissue transglutaminase and antiendomysial). NCGS/NCWS…

chemistry.chemical_classificationSettore MED/09 - Medicina InternabiologyTissue transglutaminasebusiness.industryAutoantibodynutritional and metabolic diseasesHuman leukocyte antigenDiseasemedicine.diseaseGlutendigestive system diseasesPathogenesischemistryImmunologybiology.proteinmedicineEnteropathybusinessWheat allergyceliac disease
researchProduct

HLADR5 and C4BQ0 high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region

1992

HLA haplotypes, complement C4 factor and factor B immonochemical concentrations and autoantibodies titer have been studied in six patients with mild congenital adrenal hyperplasia (MC-AH), in two patients with classical congenital adrenal hyperplasia (CCAH) and in their parents. A high frequency of DR5 and C4BQO alleles have been found in MCAH patients. Moreover, C4BQO allele is carried out in three out of four cases associated with DR5. In the two CCAH patients we found a B51 and a B14 allele, the last one usually described in the non classical form of the disease in population of different ethnic origin. Signs of autoimmunity in some patients and parents have been found. C4 null alleles w…

education.field_of_studyAnti-nuclear antibodybiologybusiness.industryEndocrinology Diabetes and MetabolismPopulationAutoantibody21-HydroxylaseHuman leukocyte antigenmedicine.diseaseNull alleleEndocrinologyImmunologybiology.proteinmedicineCongenital adrenal hyperplasiaAlleleeducationbusinessJournal of Endocrinological Investigation
researchProduct

Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity

2020

Background Pemphigus is an autoimmune blistering disease of the skin and mucous membranes caused by autoantibodies against desmoglein 1 (Dsg1) and desmoglein 3 (Dsg3). Pemphigus vulgaris (PV) is the most common form of pemphigus. The aim of this study was to assess the correlation between the levels of anti-desmoglein 1 and 3 autoantibodies and the severity of PV disease. Material and Methods Nineteen newly diagnosed patients with pemphigus vulgaris were enrolled in this study. The titers of Dsg in subjects by using enzyme-linked immunosorbent assay (ELISA) were done at diagnosis time-point, 4th and 8th weeks after the initiation of treatment, and the correlation of antibodies with the oral…

education.field_of_studyOral Medicine and Pathologyintegumentary systembusiness.industryResearchMucocutaneous zonePemphigus vulgarisAutoantibodymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Desmoglein030207 dermatology & venereal diseases03 medical and health sciencesPemphigusTiter0302 clinical medicineDesmoglein 1030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASImmunologyDesmoglein 3medicinebusinesseducationGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

Fallberichte

2004

High-dose immunoglobulins (IVIG) are important agents in the treatment of numerous autoimmune disorders. In the field of dermatology, increasing numbers of patients with bullous autoimmune disorders and mixed connective tissue diseases have been treated. We successfully treated a patient with pemphigus vulgaris with IVIG, after he had developed osteonecrosis of his right femoral head while on azathioprine and corticosteroids. After reduction of oral corticosteroids, his disease flared dramatically. The addition of a high dose immunosuppressive regimen including azathioprine and dapsone failed to help. Thus high dose IVIG (2 mg/kg, 4 weeks interval) therapy was initiated and induced complete…

education.field_of_studymedicine.medical_specialtyintegumentary systembusiness.industryPemphigus vulgarisAutoantibodyConnective tissueAzathioprineDermatologyDapsonemedicine.diseaseDermatologyFemoral headmedicine.anatomical_structureDesmoglein 1Desmoglein 3medicineeducationbusinessmedicine.drugJournal der Deutschen Dermatologischen Gesellschaft
researchProduct

Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis

1998

SUMMARY Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology. Recent studies have shown that genetic factors and both cellular and humoral immunological abnormalities are important in the pathogenesis of PSC. The most prominent autoantibodies in PSC are anti-neutrophil cytoplasmic antibodies (ANCA). The autoepitopes of ANCA in PSC are not well defined. The aim of this study was to identify corresponding ANCA autoantigens in patients with PSC. A biochemical approach with enrichment and partial purification of soluble neutrophil proteins, detection of autoantibodies by Western blot and partial amino acid sequencing were used. Two new autoantigen/aut…

endocrine system diseasesAlpha-enolaseBlotting WesternCholangitis SclerosingMolecular Sequence DataImmunologyAutoimmunityEnzyme-Linked Immunosorbent Assaymedicine.disease_causedigestive systemAutoimmunityPrimary sclerosing cholangitisAntigenWestern blotmedicineHumansImmunology and AllergyAmino Acid SequenceAutoantibodiesAnti-neutrophil cytoplasmic antibodybiologymedicine.diagnostic_testdigestive oral and skin physiologyAutoantibodyOriginal ArticlesCatalasemedicine.diseasedigestive system diseasesPhosphopyruvate HydrataseImmunologybiology.proteinAntibodyClinical and Experimental Immunology
researchProduct

Bioassays for TSH Receptor Antibodies: Quo Vadis?

2015

Autoantibodies (Ab) to the TSH receptor (TSHR) are responsible for many of the clinical manifestations of Graves' disease (GD) and are specific biomarkers of this autoimmune thyroid disorder (AITD) [1,2,3]. These Ab can be measured either via competitive-binding immunoassays or with bioassays [4]. Antibody-binding assays only report the presence or absence of TSHR-Ab and their concentrations, but do not indicate their functional activity. Bioassays, in contrast, indicate whether TSHR-Ab have stimulatory or blocking activity [5]. Historically, bioassays for TSHR-Ab were research tools used to study the pathophysiology of GD. Recently, however, there are increasing data that demonstrate the c…

endocrine systemendocrine system diseasesbiologybusiness.industryEndocrinology Diabetes and MetabolismThyroidAutoantibodymedicine.diseaseeye diseasesThyroiditisThyroid disordermedicine.anatomical_structureEditorialImmunologymedicinebiology.proteinBioassayBiomarker (medicine)AntibodyChronic thyroiditisbusiness
researchProduct